The current status of treatment for colorectal cancer in China: A systematic review

Y Zhang, Z Chen, J Li - Medicine, 2017 - journals.lww.com
Background: Colorectal cancer (CRC) is one of the most common cancers all over the world,
but its epidemiology is obviously different in various regions. Methods: The treatment of CRC …

Advances and challenges in treatment of locally advanced rectal cancer

JJ Smith, J Garcia-Aguilar - Journal of clinical oncology, 2015 - ascopubs.org
Dramatic improvements in the outcomes of patients with rectal cancer have occurred over
the past 30 years. Advances in surgical pathology, refinements in surgical techniques and …

Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology

AB Benson, AP Venook, MM Al-Hawary, N Azad… - Journal of the National …, 2022 - jnccn.org
This selection from the NCCN Guidelines for Rectal Cancer focuses on management of
malignant polyps and resectable nonmetastatic rectal cancer because important updates …

PD-1 blockade in mismatch repair–deficient, locally advanced rectal cancer

A Cercek, M Lumish, J Sinopoli, J Weiss… - … England Journal of …, 2022 - Mass Medical Soc
Background Neoadjuvant chemotherapy and radiation followed by surgical resection of the
rectum is a standard treatment for locally advanced rectal cancer. A subset of rectal cancer is …

A rectal cancer organoid platform to study individual responses to chemoradiation

K Ganesh, C Wu, KP O'Rourke, BC Szeglin, Y Zheng… - Nature medicine, 2019 - nature.com
Rectal cancer (RC) is a challenging disease to treat that requires chemotherapy, radiation
and surgery to optimize outcomes for individual patients. No accurate model of RC exists to …

Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy

JJ Smith, P Strombom, OS Chow, CS Roxburgh… - JAMA …, 2019 - jamanetwork.com
Importance The watch-and-wait (WW) strategy aims to spare patients with rectal cancer
unnecessary resection. Objective To analyze the outcomes of WW among patients with …

NCCN guidelines insights: rectal cancer, version 6.2020: featured updates to the NCCN guidelines

AB Benson, AP Venook, MM Al-Hawary… - Journal of the National …, 2020 - jnccn.org
The NCCN Guidelines for Rectal Cancer provide recommendations for the diagnosis,
evaluation, treatment, and follow-up of patients with rectal cancer. These NCCN Guidelines …

Rectal cancer, version 2.2018, NCCN clinical practice guidelines in oncology

AB Benson, AP Venook, MM Al-Hawary… - Journal of the National …, 2018 - jnccn.org
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Rectal Cancer
address diagnosis, staging, surgical management, perioperative treatment, management of …

Adoption of total neoadjuvant therapy for locally advanced rectal cancer

A Cercek, CSD Roxburgh, P Strombom, JJ Smith… - JAMA …, 2018 - jamanetwork.com
Importance Treatment of locally advanced rectal (LARC) cancer involves chemoradiation,
surgery, and chemotherapy. The concept of total neoadjuvant therapy (TNT), in which …

Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer

BR McDonald, T Contente-Cuomo… - Science translational …, 2019 - science.org
Longitudinal analysis of circulating tumor DNA (ctDNA) has shown promise for monitoring
treatment response. However, most current methods lack adequate sensitivity for residual …